Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital

Detalhes bibliográficos
Autor(a) principal: Gioia,C.A.C.
Data de Publicação: 2017
Outros Autores: Lemos,A.P.S., Gorla,M.C.O., Mendoza-Sassi,R., Figueredo,B.S., Ballester,T., Von Groll,A., Wedig,B., Ethur,N.V., Bragança,L., Silva,P.E.A., Milagres,L.G.
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000500607
Resumo: Meningococcus serogroup B (MenB), clonal complex 32 (cc 32), was the Brazilian epidemic strain of meningococcal disease (MD) in the 1990’s. Currently, meningococcus serogroup C (MenC), cc 103, is responsible for most of the cases of the disease in Brazil. The aim of this study was to investigate the seroprevalence of bactericidal antibody (SBA) against representative epidemic strains of MenC, (N753/00 strain, C:23:P1.22,14-6, cc103) and MenB, (Cu385/83 strain, B:4,7:P1.15,19, cc32) in students and employees of a university hospital in the State of Rio Grande do Sul (RS, Brazil). A second MenC strain (N79/96, C:2b:P1.5-2,10, cc 8) was used as a prototype strain of Rio de Janeiro’s outbreak that occurred in the 1990’s. Our previous study showed a 9% rate of asymptomatic carriers in these same individuals. A second goal was to compare the SBA prevalence in meningococcal carriers and non-carriers. Fifty-nine percent of the studied population showed protective levels of SBA titers (log2≥2) against at least one of the three strains. About 40% of the individuals had protective levels of SBA against N753/00 and Cu385/83 strains. Nonetheless, only 22% of the individuals showed protective levels against N79/96 strain. Significantly higher antibody levels were seen in carriers compared to non-carriers (P≤0.009). This study showed that, similar to other States in Brazil, a MenC (23:P1.22,14-6, cc103) strain with epidemic potential is circulating in this hospital. Close control by the Epidemiological Surveillance Agency of RS of the number of cases of MD caused by MenC strains in the State is recommended to prevent a new disease outbreak.
id ABDC-1_8384705e9b794e2b59b4cb5621ad4935
oai_identifier_str oai:scielo:S0100-879X2017000500607
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University HospitalNeisseria meningitidisBactericidal antibodiesMeningococcal carrierMeningococcus serogroup B (MenB), clonal complex 32 (cc 32), was the Brazilian epidemic strain of meningococcal disease (MD) in the 1990’s. Currently, meningococcus serogroup C (MenC), cc 103, is responsible for most of the cases of the disease in Brazil. The aim of this study was to investigate the seroprevalence of bactericidal antibody (SBA) against representative epidemic strains of MenC, (N753/00 strain, C:23:P1.22,14-6, cc103) and MenB, (Cu385/83 strain, B:4,7:P1.15,19, cc32) in students and employees of a university hospital in the State of Rio Grande do Sul (RS, Brazil). A second MenC strain (N79/96, C:2b:P1.5-2,10, cc 8) was used as a prototype strain of Rio de Janeiro’s outbreak that occurred in the 1990’s. Our previous study showed a 9% rate of asymptomatic carriers in these same individuals. A second goal was to compare the SBA prevalence in meningococcal carriers and non-carriers. Fifty-nine percent of the studied population showed protective levels of SBA titers (log2≥2) against at least one of the three strains. About 40% of the individuals had protective levels of SBA against N753/00 and Cu385/83 strains. Nonetheless, only 22% of the individuals showed protective levels against N79/96 strain. Significantly higher antibody levels were seen in carriers compared to non-carriers (P≤0.009). This study showed that, similar to other States in Brazil, a MenC (23:P1.22,14-6, cc103) strain with epidemic potential is circulating in this hospital. Close control by the Epidemiological Surveillance Agency of RS of the number of cases of MD caused by MenC strains in the State is recommended to prevent a new disease outbreak.Associação Brasileira de Divulgação Científica2017-01-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000500607Brazilian Journal of Medical and Biological Research v.50 n.5 2017reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20175590info:eu-repo/semantics/openAccessGioia,C.A.C.Lemos,A.P.S.Gorla,M.C.O.Mendoza-Sassi,R.Figueredo,B.S.Ballester,T.Von Groll,A.Wedig,B.Ethur,N.V.Bragança,L.Silva,P.E.A.Milagres,L.G.eng2019-03-19T00:00:00Zoai:scielo:S0100-879X2017000500607Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-03-19T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
title Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
spellingShingle Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
Gioia,C.A.C.
Neisseria meningitidis
Bactericidal antibodies
Meningococcal carrier
title_short Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
title_full Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
title_fullStr Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
title_full_unstemmed Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
title_sort Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
author Gioia,C.A.C.
author_facet Gioia,C.A.C.
Lemos,A.P.S.
Gorla,M.C.O.
Mendoza-Sassi,R.
Figueredo,B.S.
Ballester,T.
Von Groll,A.
Wedig,B.
Ethur,N.V.
Bragança,L.
Silva,P.E.A.
Milagres,L.G.
author_role author
author2 Lemos,A.P.S.
Gorla,M.C.O.
Mendoza-Sassi,R.
Figueredo,B.S.
Ballester,T.
Von Groll,A.
Wedig,B.
Ethur,N.V.
Bragança,L.
Silva,P.E.A.
Milagres,L.G.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gioia,C.A.C.
Lemos,A.P.S.
Gorla,M.C.O.
Mendoza-Sassi,R.
Figueredo,B.S.
Ballester,T.
Von Groll,A.
Wedig,B.
Ethur,N.V.
Bragança,L.
Silva,P.E.A.
Milagres,L.G.
dc.subject.por.fl_str_mv Neisseria meningitidis
Bactericidal antibodies
Meningococcal carrier
topic Neisseria meningitidis
Bactericidal antibodies
Meningococcal carrier
description Meningococcus serogroup B (MenB), clonal complex 32 (cc 32), was the Brazilian epidemic strain of meningococcal disease (MD) in the 1990’s. Currently, meningococcus serogroup C (MenC), cc 103, is responsible for most of the cases of the disease in Brazil. The aim of this study was to investigate the seroprevalence of bactericidal antibody (SBA) against representative epidemic strains of MenC, (N753/00 strain, C:23:P1.22,14-6, cc103) and MenB, (Cu385/83 strain, B:4,7:P1.15,19, cc32) in students and employees of a university hospital in the State of Rio Grande do Sul (RS, Brazil). A second MenC strain (N79/96, C:2b:P1.5-2,10, cc 8) was used as a prototype strain of Rio de Janeiro’s outbreak that occurred in the 1990’s. Our previous study showed a 9% rate of asymptomatic carriers in these same individuals. A second goal was to compare the SBA prevalence in meningococcal carriers and non-carriers. Fifty-nine percent of the studied population showed protective levels of SBA titers (log2≥2) against at least one of the three strains. About 40% of the individuals had protective levels of SBA against N753/00 and Cu385/83 strains. Nonetheless, only 22% of the individuals showed protective levels against N79/96 strain. Significantly higher antibody levels were seen in carriers compared to non-carriers (P≤0.009). This study showed that, similar to other States in Brazil, a MenC (23:P1.22,14-6, cc103) strain with epidemic potential is circulating in this hospital. Close control by the Epidemiological Surveillance Agency of RS of the number of cases of MD caused by MenC strains in the State is recommended to prevent a new disease outbreak.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000500607
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000500607
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1414-431x20175590
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.50 n.5 2017
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302945521827840